Fredun Pharmaceuticals Ltd — Important, 11-02-2026: Company Update

Fredun Pharmaceuticals has disclosed its consolidated financial results for the quarter and nine months ended December 31, 2025, approved by its Board on February 9, 2026. For the quarter, Total Income from Operations was ₹160.92 Cr, with Net Profit after Tax at ₹10.48 Cr and Basic EPS at ₹19.53. For the nine-month period, Total Income from Operations stood at ₹426.07 Cr, and Net Profit after Tax was ₹26.68 Cr, with Basic EPS at ₹49.71. These results provide an update on the company's financial performance.